[Problems in the long-term medical treatment of sequelae of acute cerebrovascular diseases. Double-blind studies].
D002561:Cerebrovascular Disorders / Q000150:complications / Q000188:drug therapy*; D003072:Cognition Disorders / Q000188:drug therapy; D004644:Emotions / Q000187:drug effects; D006261:Headache / Q000188:drug therapy; D006801:Humans; D008606:Mental Processes / Q000187:drug effects; D009043:Motor Activity / Q000187:drug effects; D009069:Movement Disorders / Q000188:drug therapy; D010208:Papaverine / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use*; D010891:Piribedil / Q000494:pharmacology / Q000627:therapeutic use*; D012893:Sleep Wake Disorders / Q000188:drug therapy; D014012:Tinnitus / Q000188:drug therapy; D014717:Vertigo / Q000188:drug therapy
D010879:Piperazines; D010208:Papaverine; D010891:Piribedil
Problematiche del trattamento medico a lungo termine dei postumi delle cerebrovasculopatie acute. Confronto doppio cieco